search
Back to results

Respiration Rate Monitoring in COPD Patients

Primary Purpose

Pulmonary Disease, Chronic Obstructive

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Reassure Non-Contact Respiration Monitor
Sponsored by
ResMed
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pulmonary Disease, Chronic Obstructive

Eligibility Criteria

35 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Males or females age ≥35 years old
  • Documented diagnosis of moderate to very severe COPD (GOLD Level II-IV)
  • Weight ≥35 kg
  • Currently using the COPD Co-PILOT application (at least 3 months with 70% compliance)
  • Must be able to read and understand English and consent for themselves

Exclusion Criteria:

  • Currently using any form of non-invasive positive airway pressure ventilation
  • Diagnosis of significant heart failure (NYHA Class III or IV)
  • Cognitive impairment (determined by physician) that will make it hard to follow instructions regarding device usage
  • BMI ≥45.5
  • Residing in hospice care, Skilled Nursing Facilities or Long Term Acute Care facilities
  • Currently using a wearable drug infusion pump to deliver medication
  • Planned procedures at time of enrollment that will occur within timeframe of study and require hospitalization etc.
  • Declines to participate at any time.
  • In the opinion of the Investigator, may be non-compliant with study schedules or procedures
  • No cellular coverage at their primary residence

Sites / Locations

  • HGE Health Care Solutions

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Respiration rate monitoring

Arm Description

Reassure Non-Contact Respiration Monitor

Outcomes

Primary Outcome Measures

Correlation of Respiration Rate to Indicators of Healthcare Utilization
Indicators of healthcare utilization include change in medications for COPD, number of office or ER visits, number of hospitalizations.

Secondary Outcome Measures

Sensitivity and Specificity of Respiration Rate to Predict COPD Worsening
Sensitivity and Specificity of Respiration Rate in Conjunction with COPD Co-PILOT Scores to Predict COPD Worsening
Correlation of Respiration Rate to COPD Episode Duration
Episode duration is defined by number of days from COPD Co-PILOT Score >1 to resolution (COPD Co-PILOT Score <1 for 7 consecutive days)

Full Information

First Posted
November 18, 2016
Last Updated
November 14, 2017
Sponsor
ResMed
search

1. Study Identification

Unique Protocol Identification Number
NCT03030313
Brief Title
Respiration Rate Monitoring in COPD Patients
Official Title
Assessment of the Temporal Changes in Nightly Respiration Rate in Combination With a Daily Symptom Reporting Application for Facilitating Early Treatment of Symptoms in COPD Patients
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
December 1, 2016 (Actual)
Primary Completion Date
July 26, 2017 (Actual)
Study Completion Date
July 26, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ResMed

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Assess the feasibility of using remote respiration rate monitoring as a component of home care, how respiration rate data may be used in combination with other data to potentially improve response to symptoms, and to generate data to inform the endpoints and effect sizes of future studies.
Detailed Description
The research question is whether monitoring of respiration rates and variability can be helpful in management of COPD patients in conjunction with or separately from self-reported symptom scores using the COPD Co-PILOT application. Current techniques (such as patient's self-reported symptoms) have limited sensitivity and specificity with regard to predicting decompensation. Measurement of respiration parameters and the variability of the parameters may detect worsening COPD. Changes in respiration patterns may occur sufficiently far in advance of decompensation (e.g. >5 days prior to patient symptoms) such that it would allow an opportunity for earlier intervention with medical assessment and current therapeutic approaches. The specific primary aim includes evaluation of the correlation of respiration rate parameters to indicators of healthcare utilization including drug changes, office or ER visits, hospitalization, or other clinical interventions. Secondary aims include evaluation of (i) the sensitivity and specificity of respiration rate monitoring results to predict COPD worsening requiring medical intervention, (ii) the sensitivity and specificity of respiration rate monitoring results in conjunction with COPD Co-PILOT scores or components to predict COPD worsening requiring medical intervention, and the correlation of respiration rate parameters to episode duration as defined by number of days from COPD Co-PILOT Score >1 to resolution (COPD Co-PILOT Score <1 for 7 consecutive days).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Respiration rate monitoring
Arm Type
Experimental
Arm Description
Reassure Non-Contact Respiration Monitor
Intervention Type
Device
Intervention Name(s)
Reassure Non-Contact Respiration Monitor
Intervention Description
Reassure Respiration Monitor uses very low power radio waves to detect respiratory movements of a person while asleep in bed - without physical contact with the individual. Algorithms analyze the respiratory movement signals and extract information about respiration rate and variability. This data is uploaded to a secure cloud infrastructure for storage.
Primary Outcome Measure Information:
Title
Correlation of Respiration Rate to Indicators of Healthcare Utilization
Description
Indicators of healthcare utilization include change in medications for COPD, number of office or ER visits, number of hospitalizations.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Sensitivity and Specificity of Respiration Rate to Predict COPD Worsening
Time Frame
Baseline to 12 weeks
Title
Sensitivity and Specificity of Respiration Rate in Conjunction with COPD Co-PILOT Scores to Predict COPD Worsening
Time Frame
12 weeks
Title
Correlation of Respiration Rate to COPD Episode Duration
Description
Episode duration is defined by number of days from COPD Co-PILOT Score >1 to resolution (COPD Co-PILOT Score <1 for 7 consecutive days)
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Males or females age ≥35 years old Documented diagnosis of moderate to very severe COPD (GOLD Level II-IV) Weight ≥35 kg Currently using the COPD Co-PILOT application (at least 3 months with 70% compliance) Must be able to read and understand English and consent for themselves Exclusion Criteria: Currently using any form of non-invasive positive airway pressure ventilation Diagnosis of significant heart failure (NYHA Class III or IV) Cognitive impairment (determined by physician) that will make it hard to follow instructions regarding device usage BMI ≥45.5 Residing in hospice care, Skilled Nursing Facilities or Long Term Acute Care facilities Currently using a wearable drug infusion pump to deliver medication Planned procedures at time of enrollment that will occur within timeframe of study and require hospitalization etc. Declines to participate at any time. In the opinion of the Investigator, may be non-compliant with study schedules or procedures No cellular coverage at their primary residence
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gerard Criner, MD
Organizational Affiliation
Temple University
Official's Role
Principal Investigator
Facility Information:
Facility Name
HGE Health Care Solutions
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19129
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Respiration Rate Monitoring in COPD Patients

We'll reach out to this number within 24 hrs